Kelly E. R. Bachta

ORCID: 0000-0001-8838-5117
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Resistance in Bacteria
  • Bacterial biofilms and quorum sensing
  • SARS-CoV-2 and COVID-19 Research
  • Bacterial Identification and Susceptibility Testing
  • Clostridium difficile and Clostridium perfringens research
  • Antimicrobial Resistance in Staphylococcus
  • Mycobacterium research and diagnosis
  • Gut microbiota and health
  • Probiotics and Fermented Foods
  • Animal Virus Infections Studies
  • interferon and immune responses
  • Genomics and Phylogenetic Studies
  • COVID-19 Clinical Research Studies
  • Enterobacteriaceae and Cronobacter Research
  • Viral gastroenteritis research and epidemiology
  • Plant Pathogenic Bacteria Studies
  • Microbial Metabolism and Applications
  • Vibrio bacteria research studies
  • Invertebrate Immune Response Mechanisms
  • Pericarditis and Cardiac Tamponade
  • Respiratory viral infections research
  • Antimicrobial Peptides and Activities
  • Long-Term Effects of COVID-19
  • Bacteriophages and microbial interactions
  • Drug Transport and Resistance Mechanisms

Northwestern University
2019-2024

Kelly Services (United States)
2021

Abstract Health care-associated infections such as Pseudomonas aeruginosa bacteremia pose a major clinical risk for hospitalized patients. However, these systemic are presumed to be “dead-end” P. and have no impact on transmission. Here, we use mouse infection model show that can spread from the bloodstream gallbladder, where it replicates extremely high numbers. Bacteria in gallbladder then seed intestines feces, leading transmission uninfected cage-mate mice. Our work shows is crucial of...

10.1038/s41467-020-14363-4 article EN cc-by Nature Communications 2020-01-28
Oleksandra Herasymenko Madhushika Silva Abd Al‐Aziz A. Abu‐Saleh Ayaz Ahmad Jesus Antonio Alvarado-Huayhuaz and 95 more Oscar E. A. Arce Roly J. Armstrong C.H. Arrowsmith Kelly E. R. Bachta Hartmut Beck Dénes Berta M. Bieniek Vincent Blay Albina Bolotokova Philip E. Bourne Marco Breznik Peter J. Brown Aaron D. G. Campbell Emanuele Carosati Irene Chau D. J. A. Cole Ben Cree Wim Dehaen Katrin Denzinger Karina Machado Ian Dunn Prasannavenkatesh Durai Kristina Edfeldt A.M. Edwards Darren Fayne Kallie Friston Pegah Ghiabi Elisa Gibson Judith Guenther Anders Gunnarsson Alexander Hillisch Douglas R. Houston Jan H. Jensen Rachel Harding Claire L. Harris Laurent Hoffer Anders Hogner Joshua T. Horton Scott Houliston Judd F. Hultquist Ashley Hutchinson John J. Irwin Marko Jukič Shubhangi Kandwal Andrea Karlova V.L. Katis Ryan P. Kich Dmitri Kireev David Ryan Koes Nicole L. Inniss Uta Lessel Sijie Liu P. Loppnau Wei Lu Sam Alexander Martino Miles McGibbon Jens Meiler Akhila Mettu Sam Money-Kyrle Rocco Moretti Yurii S. Moroz Charuvaka Muvva J.A. Newman Leon Obendorf Brooks Paige Amit Pandit Keunwan Park Sumera Perveen Rachael Pirie Gennady Poda M. V. Protopopov Vera Pütter Federico Ricci Natalie J. Roper Edina Rosta Margarita Rzhetskaya Yogesh Sabnis K.J.F. Satchell Frederico Schmitt Kremer Thomas W. Scott Almagul Seitova Casper Steinmann Valerij Talagayev Olga O. Tarkhanova Natalie J. Tatum Dakota Treleaven Adriano Velasque Werhli W. Patrick Walters Xiaowen Wang Jude Wells Geoffrey Wells Yvonne Westermaier Gerhard Wolber Lars Wortmann Jixian Zhang

A critical assessment of computational hit finding experiments (CACHE) challenge was conducted to predict ligands for the SARS-CoV-2 Nsp13 helicase RNA binding site, a highly conserved COVID-19 target. Twenty-three participating teams comprised chemists and data scientists used protein structure from fragment-screening paired with advanced machine learning methods each up 100 inhibitory ligands. Across all teams, 1957 compounds were predicted subsequently procured commercial catalogs...

10.26434/chemrxiv-2025-8f0rq preprint EN cc-by 2025-03-04
Oleksandra Herasymenko Madhushika Silva Abd Al‐Aziz A. Abu‐Saleh Ayaz Ahmad Jesus Antonio Alvarado-Huayhuaz and 95 more Oscar E. A. Arce Roly J. Armstrong C. Arrowsmith Kelly E. R. Bachta Hartmut Beck Dénes Berta M. Bieniek Vincent Blay Albina Bolotokova Philip E. Bourne Marco Breznik Peter J. Brown Aaron D. G. Campbell Emanuele Carosati Irene Chau D. J. A. Cole Ben Cree Wim Dehaen Katrin Denzinger Karina Machado Ian Dunn Prasannavenkatesh Durai Kristina Edfeldt A.M. Edwards Darren Fayne Kallie Friston Pegah Ghiabi Elisa Gibson Judith Günther Anders Gunnarsson Alexander Hillisch Douglas R. Houston Jan H. Jensen Rachel Harding Claire L. Harris Laurent Hoffer Anders Hogner Joshua T. Horton Scott Houliston Judd F. Hultquist Ashley Hutchinson John J. Irwin Marko Jukič Shubhangi Kandwal Andrea Karlova V.L. Katis Ryan P. Kich Dmitri Kireev David Ryan Koes Nicole L. Inniss Uta Lessel Sijie Liu P. Loppnau Wei Lu Sam Alexander Martino Miles McGibbon Jens Meiler Akhila Mettu Sam Money-Kyrle Rocco Moretti Yurii S. Moroz Charuvaka Muvva J.A. Newman Leon Obendorf Brooks Paige Amit Pandit Keunwan Park Sumera Perveen Rachael Pirie Gennady Poda M. V. Protopopov Vera Pütter Federico Ricci Natalie J. Roper Edina Rosta Margarita Rzhetskaya Yogesh Sabnis K.J.F. Satchell Frederico Schmitt Kremer T. W. Scott Almagul Seitova Casper Steinmann Valerij Talagayev Olga O. Tarkhanova Natalie J. Tatum Dakota Treleaven Adriano Velasque Werhli W. Patrick Walters Xiaowen Wang Jude Wells Geoffrey Wells Yvonne Westermaier Gerhard Wolber Lars Wortmann Jixian Zhang

A critical assessment of computational hit finding experiments (CACHE) challenge was conducted to predict ligands for the SARS-CoV-2 Nsp13 helicase RNA binding site, a highly conserved COVID-19 target. Twenty-three participating teams comprised chemists and data scientists used protein structure from fragment-screening paired with advanced machine learning methods each up 100 inhibitory ligands. Across all teams, 1957 compounds were predicted subsequently procured commercial catalogs...

10.26434/chemrxiv-2025-8f0rq-v2 preprint EN cc-by 2025-03-05
Oleksandra Herasymenko Madhushika Silva Abd Al‐Aziz A. Abu‐Saleh Ayaz Ahmad Jesus Antonio Alvarado-Huayhuaz and 95 more Oscar E. A. Arce Roly J. Armstrong C. Arrowsmith Kelly E. R. Bachta Hartmut Beck Dénes Berta M. Bieniek Vincent Blay Albina Bolotokova Philip E. Bourne Marco Breznik Peter J. Brown Aaron D. G. Campbell Emanuele Carosati Irene Chau D. J. A. Cole Ben Cree Wim Dehaen Katrin Denzinger Karina Machado Ian Dunn Prasannavenkatesh Durai Kristina Edfeldt A.M. Edwards Darren Fayne Kallie Friston Pegah Ghiabi Elisa Gibson Judith Günther Anders Gunnarsson Alexander Hillisch Douglas R. Houston Jan H. Jensen Rachel Harding Claire L. Harris Laurent Hoffer Anders Hogner Joshua T. Horton Scott Houliston Judd F. Hultquist Ashley Hutchinson John J. Irwin Marko Jukič Shubhangi Kandwal Andrea Karlova V.L. Katis Ryan P. Kich Dmitri Kireev David Ryan Koes Nicole L. Inniss Uta Lessel Sijie Liu P. Loppnau Wei Lu Sam Alexander Martino Miles McGibbon Jens Meiler Akhila Mettu Sam Money-Kyrle Rocco Moretti Yurii S. Moroz Charuvaka Muvva J.A. Newman Leon Obendorf Brooks Paige Amit Pandit Keunwan Park Sumera Perveen Rachael Pirie Gennady Poda M. V. Protopopov Vera Pütter Federico Ricci Natalie J. Roper Edina Rosta Margarita Rzhetskaya Yogesh Sabnis K.J.F. Satchell Frederico Schmitt Kremer T. W. Scott Almagul Seitova Casper Steinmann Valerij Talagayev Olga O. Tarkhanova Natalie J. Tatum Dakota Treleaven Adriano Velasque Werhli W. Patrick Walters Xiaowen Wang Jude Wells Geoffrey Wells Yvonne Westermaier Gerhard Wolber Lars Wortmann Jixian Zhang

A critical assessment of computational hit finding experiments (CACHE) challenge was conducted to predict ligands for the SARS-CoV-2 Nsp13 helicase RNA binding site, a highly conserved COVID-19 target. Twenty-three participating teams comprised chemists and data scientists used protein structure from fragment-screening paired with advanced machine learning methods each up 100 inhibitory ligands. Across all teams, 1957 compounds were predicted subsequently procured commercial catalogs...

10.26434/chemrxiv-2025-8f0rq-v3 preprint EN cc-by 2025-03-06

ABSTRACT Pseudomonas aeruginosa is a common nosocomial pathogen and major cause of morbidity mortality in hospitalized patients. Multiple reports highlight that P. gastrointestinal colonization may precede systemic infections by this pathogen. Gaining deeper insight into the dynamics carriage an essential step managing could contribute to preventing bacterial transmission progression infection. Here, we present clinically relevant mouse model relying on parenteral vancomycin pretreatment...

10.1128/mbio.03136-24 article EN cc-by mBio 2025-04-10

is a common cause of difficult-to-treat infections due to its propensity express resistance many antibiotics. For example, carbapenem-resistant

10.1128/mbio.02128-23 article EN cc-by mBio 2023-10-25

The SARS-CoV-2 nucleocapsid (N) protein is highly immunogenic, and anti-N antibodies are commonly used as markers for prior infection. While several studies have examined or predicted the antigenic regions of N, these lacked consensus structural context. Using COVID-19 patient sera to probe an overlapping peptide array, we identified six public four private epitope across some which unique this study. We further report first deposited X-ray structure stable dimerization domain at 2.05 Å...

10.1128/spectrum.00324-23 article EN cc-by Microbiology Spectrum 2023-05-16

Antimicrobial resistance (AMR) is a major challenge in the treatment of infections caused by Pseudomonas aeruginosa. Highly drug-resistant are disproportionally small subset globally distributed P. aeruginosa sequence types (STs), termed "high-risk clones." We noted that clonal complex (CC) 446 (which includes STs 298 and 446) isolates were repeatedly cultured at 1 medical center asked whether this lineage might constitute an emerging high-risk clone.We searched genomes from collections...

10.1093/cid/ciz973 article EN Clinical Infectious Diseases 2019-10-01

While several demographic and clinical correlates of coronavirus disease 2019 (COVID-19) outcome have been identified, their relationship to virological immunological parameters remains poorly defined.

10.1093/ofid/ofac027 article EN cc-by-nc-nd Open Forum Infectious Diseases 2022-02-14

SARS-CoV-2 nsp13 helicase is an essential enzyme for viral replication and a promising target antiviral drug development. This study compares the double-stranded RNA (dsRNA) unwinding activity of Omicron nsp13R392C variant, which predominant in currently circulating lineages. Using vitro gel- fluorescence-based assays, we found that both have dsRNA with equivalent kinetics. Furthermore, R392C mutation had no effect on efficiency nsp13-specific inhibitor SSYA10-001. We additionally confirmed...

10.1016/j.slasd.2024.01.006 article EN cc-by-nc-nd SLAS DISCOVERY 2024-02-01

is an emerging pathogen increasingly implicated in health care-associated infections. Here, we report a case of recurrent ventricular assist device-associated infection caused by multidrug-resistant

10.1093/ofid/ofae611 article EN cc-by-nc-nd Open Forum Infectious Diseases 2024-10-09

Resistance to antipseudomonal penicillins and cephalosporins is often driven by the overproduction of intrinsic β-lactamase AmpC. However, OXA-10-family β-lactamases are a rich source resistance in Pseudomonas aeruginosa. OXA have propensity for mutation that leads extended spectrum cephalosporinase carbapenemase activity. In this study, we identified isolates from subclade multidrug-resistant (MDR) high risk P. aeruginosa clonal complex CC446 with ceftazidime. A genomic analysis revealed...

10.1128/aac.00985-22 article EN cc-by Antimicrobial Agents and Chemotherapy 2022-09-21

Purpose: Mortality associated with Pseudomonas aeruginosa bloodstream infection (PABSI) remains high despite advances in clinical care and therapeutics. In a recent study using mice to model PABSI, the gallbladder (GB) was identified as reservoir for bacterial expansion. Furthermore, bile exposure has been linked increased antimicrobial resistance (AMR). Therefore, we asked whether patients retained gallbladders might suffer from more resistant P. (Pa) infections, extended culture...

10.1101/2024.01.26.24301822 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-01-26

is a common nosocomial pathogen and major cause of morbidity mortality in hospitalized patients. Multiple reports highlight that

10.1101/2024.08.19.608679 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-08-20

Lacticaseibacillus (formerly Lactobacillus) rhamnosus is widely used in probiotics or food supplements to promote microbiome health and may also be part of the normal microbiota human gastrointestinal tract. However, it rarely causes invasive severe infections patients. It has been postulated that these originate from endogenous commensal reservoirs. In this report, we examine population structure investigate utility using bacterial genomics identify source infections.

10.1371/journal.pone.0300843 article EN cc-by PLoS ONE 2024-08-30

ABSTRACT Larvae of Galleria mellonella (the greater wax moth) are being increasingly used as a model to study microbial pathogenesis. In this model, bacterial virulence is typically measured by determining the 50% lethal dose (LD 50 ) strain or mutant. The use G. Pseudomonas aeruginosa pathogenesis, however, challenging because extreme sensitivity larvae bacterium. For some P. strains, few 1–5 colony-forming units sufficient kill mellonella, which poses challenges for LD values. reason,...

10.1128/spectrum.01666-24 article EN cc-by Microbiology Spectrum 2024-12-12

ABSTRACT Gastrointestinal (GI) colonization by Klebsiella pneumoniae is a risk factor for subsequent infection as well transmission to other patients. Additionally, achieved many strain types that exhibit high diversity in genetic content. Thus, we aimed study strain-specific requirements K. GI applying transposon insertion sequencing three classical clinical strains: carbapenem-resistant strain, an extended-spectrum beta-lactamase producing and non-epidemic antibiotic-susceptible strain....

10.1101/2023.08.30.555643 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2023-08-31

The Gram-negative bacterium Pseudomonas aeruginosa is often multidrug resistant, associated with global epidemic outbreaks, and responsible for significant morbidity mortality in hospitalized patients. Here, we present the draft genome sequence of BWH047, a multidrug-resistant P. clinical isolate belonging to type 235 demonstrating high levels colistin resistance.

10.1128/mra.00623-19 article EN Microbiology Resource Announcements 2019-07-17

Abstract Background Vancomycin-resistant enterococci (VRE) are nosocomial pathogens with extensive intrinsic and acquired antimicrobial resistance (AMR) mechanisms. We report a case in which intraabdominal (IA) blood cultures grew linezolid daptomycin resistant VRE (DLVRE). Methods of DLVRE bacteremia after prolonged treatment daptomycin. Results The patient was 65-year-old female history multiple abdominal surgeries who presented for elective incisional hernia repair. Her post-operative...

10.1093/ofid/ofab466.1442 article EN cc-by Open Forum Infectious Diseases 2021-11-01

ABSTRACT Health care-associated infections such as Pseudomonas aeruginosa (PA) bacteremia pose a major clinical risk for hospitalized patients, and efforts to limit them are priority. The fitness pressures accounting PA virulence factors that facilitate bloodstream unclear, these presumed be “dead-end” have no impact on transmission. Here, we used mouse model show spreads from the gallbladder, where it replicates extremely high numbers. Bacteria in gallbladder then seed intestines feces,...

10.1101/765339 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2019-09-12

Abstract Background Antimicrobial resistance (AMR) poses an increasing challenge to the treatment of nosocomial pathogen Pseudomonas aeruginosa, with majority highly resistant infections caused by relatively few high-risk clones. We investigated role clonal complex 298 (CC298: ST298 and ST446) in multidrug-resistant (MDR) extensively drug-resistant (XDR) at Northwestern Memorial Hospital (NMH). Methods determined AMR 40 whole-genome sequenced CC298 isolates, including 30 from patients NMH...

10.1093/ofid/ofz360.2131 article EN cc-by-nc-nd Open Forum Infectious Diseases 2019-10-01

Abstract Background Pseudomonas aeruginosa (PA) is a critically important healthcare-associated pathogen responsible for variety of infections including bloodstream infection (bacteremia), pneumonia, and urinary tract infection. PA bacteremia significant cause morbidity mortality, especially in immunocompromised patients; However, little known about the in-host dynamics impact individually infected patients on transmission healthcare environment. Methods We utilized animal modeling...

10.1093/ofid/ofz360.2244 article EN cc-by-nc-nd Open Forum Infectious Diseases 2019-10-01

Abstract Background Pseudomonas aeruginosa (PA) is an important cause of healthcare-associated infections including pneumonia and bloodstream (bacteremia). PA a significant morbidity mortality, especially in immunocompromised patients those on prolonged mechanical ventilation; However, little known about the in-host infection dynamics its relationship to transmission. Methods We utilized mouse model conjunction with sequencing technology dissect pneumonia. BALB/c mice were challenged...

10.1093/ofid/ofaa417.043 article EN cc-by-nc-nd Open Forum Infectious Diseases 2020-10-01
Coming Soon ...